Ajanta Pharma Ltd gets Form 483 with 2 procedural observations for Dahej Formulation facility

Ajanta Pharma Ltd's formulation facility at Dahej was inspected by US FDA from 5th September 2022 to 9th September 2022.

At the end of the inspection, Form 483 was issued to us with 2 procedural observations. The company is in the process of responding to the same within the stipulated time prescribed by US FDA.

Source : Equity Bulls

Keywords

AjantaPharma FormulationFacility Dahej USFDA Inspection Form483 2Observations